dibenzylchlorethamine has been researched along with Spinal Cord Diseases in 1 studies
Dibenzylchlorethamine: An alpha adrenergic antagonist.
Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurden, GG | 1 |
| Feringa, ER | 1 |
1 other study available for dibenzylchlorethamine and Spinal Cord Diseases
| Article | Year |
|---|---|
Effects of sympatholytic agents on CNS regeneration, cystic necrosis after spinal cord transection.
Topics: Animals; Cysts; Dibenzylchlorethamine; Disease Models, Animal; Evaluation Studies as Topic; Methylty | 1974 |